Landscape of new drugs and targets in inflammatory bowel disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Landscape of new drugs and targets in inflammatory bowel disease

Published:2022-09-16 Issue:10 Volume:10 Page:1129-1166
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:UEG Journal

Author:

Vieujean Sophie¹^ORCID,D’Amico Ferdinando²³^ORCID,Netter Patrick⁴,Danese Silvio²,Peyrin‐Biroulet Laurent⁵⁶^ORCID

Affiliation:

1. Hepato‐Gastroenterology and Digestive Oncology University Hospital CHU of Liège Liège Belgium

2. Department of Gastroenterology and Endoscopy IRCCS San Raffaele Hospital and Vita‐Salute San Raffaele University Milan Italy

3. Department of Biomedical Sciences Humanitas University Pieve Emanuele Milan Italy

4. Université de Lorraine CNRS Laboratoire IMoPA Nancy France

5. Department of Gastroenterology University of Lorraine CHRU‐Nancy Nancy France

6. University of Lorraine Inserm, NGERE Nancy France

Funder

Fonds De La Recherche Scientifique - FNRS

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ueg2.12305

Reference225 articles.

1. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

2. Long-term Infliximab Maintenance Therapy for Ulcerative Colitis: The ACT-1 and -2 Extension Studies

3. Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease

4. Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months

5. Long-Term Benefit of Golimumab for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the PURSUIT-Maintenance Extension

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DAMP-ing IBD: Extinguish the Fire and Prevent Smoldering;Digestive Diseases and Sciences;2024-07-04

2. It’s Time to Change Tack in IBD Treatment;Gastroenterology;2024-07

3. Deciphering Microbial Composition in Patients with Inflammatory Bowel Disease: Implications for Therapeutic Response to Biologic Agents;Microorganisms;2024-06-21

4. Chronic Kidney Disease in Inflammatory Bowel Disease: a Systematic Review and Meta-analysis;Journal of Crohn's and Colitis;2024-04-08

5. The Exacerbating Effects of the Tumor Necrosis Factor in Cardiovascular Stenosis: Intimal Hyperplasia;Cancers;2024-04-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3